MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology _ Genomics, Genetic Testing, Gene & DNA Sequencing, NGS (Next Generation Sequencing) Companies
Singlera Genomics
Attachments
Maintenance mode
Parents
*Architects: Biotechnology _ Genomics, Genetic Testing, Gene & DNA Sequencing, NGS (Next Generation Sequencing) Companies
*Architects: Diagnostics_Liquid Biopsy
*Industry: San Diego, California
Industry: China
Venture Capital: Series B
Children
2020: Series B financing led by CICC Kai Tak Innovative Biomedicine Fund, Detong Capital, Furong Investment, Huamei International, Linden Asset Group, Wuxi Capital, FutureX Skyline Capital, Shanghai Free Trade Zone Fund, Greenpine Capital, Prosperico Ventures, and Proxima Ventures
2020: Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products
Developing the next generation of genetic testing and molecular diagnostic technologies
Focusing on the development and application of non-invasive early screening and diagnosis technology, the company developed a patented methylation detection platform for early tumor diagnostics and prevention.
Founded 2014
Johny Zhang, co-founder and CEO of Singlera (2020)
San Diego, California
Shanghai, China
Singlera has proprietary technologies in single cell sequencing, DNA methylation, and bioinformatics.
Singlera's circulating tumor DNA (ctDNA) methylation multi-cancer screening technology PanSeer®
Yuan Gao, co-founder and scientific advisor of Singlera (2020)
Jumps
Fudan University